
MARKET PULSE Last week's two big moves pulled in opposite directions. The Nasdaq closed in a correction Thursday as the AI trade sold off. Then employers added 165,000 jobs in October, more than double forecasts. Kalshi's December hike contract fell to about 66 cents Thursday, from 80 cents that morning. After Friday's jobs report, futures priced about a 78% chance of a December hike, Reuters reported. Inflation now decides which move the Fed weighs. October consumer prices are the last before the Dec. 8 to 9 meeting. The Treasury also sells $125 billion of notes and bonds, with a holiday in the middle. Two AI suppliers report into a chip index that was down about 13% for the week by Friday afternoon. Oil sits below $100 with no deal behind it. Texas has a governor-elect who pledged to pause data-center approvals. The six items below split into four dated events and two open questions.
DATED EVENTS TUESDAY, NOV. 10, 8:30 A.M., AND FRIDAY, NOV. 13, 8:30 A.M. | THE LAST PRICES BEFORE THE FED October consumer prices arrive Tuesday at 8:30 a.m. Eastern. Producer prices follow Friday at 8:30 a.m. September consumer prices rose 0.6% in the month, and core prices, which leave out food and energy, rose 0.3%. For October, the Cleveland Fed's nowcast puts the gain at about 0.24%, with core near 0.21%. RBC Economics expects 0.3% for both. Some inputs are cooling. Unit labor costs fell 0.7% last quarter, the first drop in more than a year. Consumers' year-ahead inflation expectations fell to 4.3% from 4.7%, the University of Michigan said Friday. Investor Signal Does core inflation give the Fed its December case? A core reading of 0.3% or more, after Friday's payrolls, would make a hike hard to avoid. A reading of 0.2% or less would reopen the debate the stock selloff started. Two-year notes, the dollar and long-duration growth stocks are most exposed.
MONDAY TO THURSDAY, 1 P.M. $125 BILLION OF NOTES AND BONDS The Treasury sells $58 billion of three-year notes Monday, $42 billion of 10-year notes Tuesday and $25 billion of 30-year bonds Thursday. Bids are due at 1 p.m. Eastern. The bond market closes Wednesday for Veterans Day, while stocks trade normally. The Treasury kept auction sizes unchanged but dropped "at least" from its pledge to hold them steady. Its advisory committee said bigger auctions will be warranted later in fiscal 2027. The 10-year sale comes hours after the price report. AI borrowers are competing for the same long-term money. Meta Platforms (META) paid up to 7.53% last week, and Oracle (ORCL) up to 8.65%. Investor Signal Will buyers take long bonds after a strong jobs report? A 30-year sale that clears below its 1 p.m. market yield would say long-term demand held. A large tail would lift the borrowing costs AI's builders already pay. The 30-year, mortgage rates and long-dated corporate bonds are most exposed.
FROM OUR PARTNERS This #1 stock for the next AI boom?
Behind the scenes, America's top AI scientists have been hard at work. They've been building a new category of AI-powered device so powerful… It'll trigger something AI scientists call an "intelligence explosion…" A sudden 360-fold acceleration in major AI-powered breakthroughs. That means it'd shrink AI breakthrough times from 3 years… down to 3 days. In the process, it's poised to spark a $100 trillion reset of the AI markets… starting THIS YEAR. That's why Louis Navellier believes this event could send certain AI stocks tumbling… While creating a new generation of AI millionaires and billionaires… Starting with the company he reveals here (down to the ticker) in his new presentation. This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.
TUESDAY AND THURSDAY, AFTER THE CLOSE TWO AI SUPPLIERS REPORT CoreWeave (CRWV) reports Tuesday after the close. Applied Materials (AMAT) reports Thursday after the close. CoreWeave rents out AI computing power and borrows to build it. Protection on its debt has traded above 1,000 basis points, a distress level. Its shares fell about 9.9% on Wednesday alone. Applied Materials sells chipmaking tools. Peer Lam Research (LRCX) fell 16.4% Thursday, then approved a $25 billion buyback. Investor Signal Did last week's selloff price slower orders or a crowded trade? Steady order outlooks would point to positioning. A cut to customer spending would confirm the fear behind Thursday's drop. Chip-equipment makers, AI cloud lessors and their bonds are most exposed.
MONDAY, NOV. 9, BEFORE THE OPEN KKR AND THE PRIVATE CREDIT FILINGS KKR (KKR) reports Monday before the open. Quarterly filings from business development companies, the listed private-credit funds, are due by mid-November. The strain has started to show. Morgan Stanley's private-credit fund cut its fees as its asset value fell 3.8%. KBRA counted a record 112 borrowers in default over 12 months. Blue Owl Capital Corp. (OBDC) put 2.9% of its portfolio at cost on non-accrual, up from 2.0% in March. Partners Group's U.S. evergreen fund paid about a third of withdrawal requests last quarter. Investor Signal How many loans have stopped paying? A rise in non-accruals across the filings would show strain spreading past a few funds. Steady marks would support managers who say the problem is limited. Business development companies and alternative asset managers are most exposed.
PARTNER SPOTLIGHT for America’s New Super Fuel The U.S. Army and Department of Energy are about to flip the switch on a revolutionary new fuel — and one obscure defense contractor has a five-year head start on every competitor. This joint, high-priority initiative — ordered by President Trump — is called Project Janus. And the first powerplant to run this new fuel is expected to go live before December 18, 2026… When it does, this company’s name will be everywhere. Full details — including the name and ticker symbol — are being revealed for free. 
Click HERE to get the stock name, ticker, and the full Project Janus story for free.
IRAN'S REPLY AND OIL BELOW $100 Brent fell below $100 Wednesday without a deal with Iran. It traded near $97 Friday, after reports of tanker attacks lifted it about 4% Thursday. Iran rejected Washington's latest reply on the Strait of Hormuz. Its answer through Qatar's mediators is the next step. When Brent broke $100, United Airlines (UAL) rose 8% and Exxon Mobil (XOM) fell 4.5%. Two Polymarket ceasefire contracts, for Oct. 31 and Nov. 2, were still under dispute as of Tuesday. Investor Signal Does the price hold without an agreement? A signed framework would let lower fuel costs reach inflation data. A new strike or tanker loss would restore part of the premium oil gave back. Brent, airlines, oil producers and refiners are most exposed.
TEXAS AND THE NEW CONGRESS Democrats won both chambers of Congress last week. In Texas, Democrat Gina Hinojosa won after pledging to pause data-center approvals. She takes office Jan. 19 and has not said how a pause would work. UBS (UBS) strategists said about 30% of new U.S. data-center capacity due in 2028 is at risk from construction pauses. Vistra (VST) fell 13.8% Wednesday, then rebounded about 10% Friday. Riot Platforms (RIOT) rose 9.6% on a signed $28 billion lease, while Cipher Digital (CIFR) fell 20%. Investor Signal Is the pledge a pause or a freeze? A formal plan that exempts projects under way would ease pressure on power producers. A broad halt would hit the grid contractors and miners building in Texas. Power producers, grid contractors and AI-hosting bitcoin miners are most exposed.
THE CLOSE Last week showed a strong economy and a shaken AI build-out. This week asks which one sets the price of money. Prices speak Tuesday, bond buyers through Thursday and the suppliers after the close. If core inflation runs hot, the Fed hikes into a selloff. If it cools, the market gets a reason to wait.
AI Moves Into the Biotech LabFor most of the AI boom, the money followed the hardware. Chips. Data centers. Cloud. Now the algorithms are walking into the lab. In September, a drug whose target was found by AI, and whose molecule was designed by AI, dosed its first patient in a Phase III trial. A second AI-engineered medicine is in Phase III too. We profiled the 5 companies leading the shift in a new FREE Special Report: AI Moves Into the Biotech Lab. We'll text it straight to your phone. Get the Free Report by Text → |